The working group for “basic science” in ITP at the International Cooperative ITP Study Group (ICIS)

Clemetson, Kenneth J.; Panzer, Simon
July 2010
Annals of Hematology;Jul2010, Vol. 89, p3
Academic Journal
A variety of studies were considered necessary to better understand the etiology of idiopathic thrombocytopenic purpura. Apoptosis of platelets and megakaryocytes were strong proposals, calling for collaboration. Some groups want to study microparticles and thombin generation in order to understand the variation of the bleeding tendency in patients. Viral antigen cross-reaction with platelet epitopes was another topic that was addressed. Kinetics of cytokines may further contribute to our understanding of the disease.


Related Articles

  • Complement profile in childhood immune thrombocytopenic purpura: a prospective pilot study. Ohali, Meli; Maizlishi, Yair; Abramov, Haya; Schlesinger, Menachem; Bransky, David; Lugassy, Gilles // Annals of Hematology;Dec2005, Vol. 84 Issue 12, p812 

    Immune thrombocytopenic purpura (ITP) is a frequent, usually acute hematologic complication of viral diseases in children. Its evolution is usually benign with spontaneous resolution. Some authors have raised the hypothesis of a possible role of the complement system in the pathogenesis of ITP....

  • Immune Thrombocytopenic Purpura. Cines, Douglas B.; Blanchette, Victor S. // New England Journal of Medicine;3/28/2002, Vol. 346 Issue 13, p995 

    Presents a review that focuses on the diagnosis and management of primary immune thrombocytopenic purpura, an auto immune disorder characterized by a low platelet count and mucocutaneous bleeding. Description of the disorder and its occurrence in children and adults; Possible causes of the...

  • Essential thrombocythemia. Brière, Jean B. // Orphanet Journal of Rare Diseases;2007, Vol. 2, p3 

    Essential thrombocythemia (ET) is an acquired myeloproliferative disorder (MPD) characterized by a sustained elevation of platelet number with a tendency for thrombosis and hemorrhage. The prevalence in the general population is approximately 30/100,000. The median age at diagnosis is 65 to 70...

  • Romiplostim use in ITP. Lohr, Lisa // Hem/Onc Today;12/25/2008, Vol. 9 Issue 23, p13 

    The article discusses the use of romiplostim in the treatment of immune thrombocytopenia or idiopathic thrombocytopenic purpura (ITP). ITP is a syndrome characterized by accelerated platelet destruction. Romiplostim is a recombinant protein that stimulates platelet production by binding to and...

  • Epidemiologic Features and Environmental Risk Factors of Severe Fever with Thrombocytopenia Syndrome, Xinyang, China. Liu, Kun; Cui, Ning; Fang, Li-Qun; Wang, Bing-Jun; Lu, Qing-Bin; Peng, Wei; Li, Hao; Wang, Li-Yuan; Liang, Song; Wang, Hong-Yu; Zhang, Yao-Yun; Zhuang, Lu; Yang, Hong; Gray, Gregory C.; de Vlas, Sake J.; Liu, Wei; Cao, Wu-Chun // PLoS Neglected Tropical Diseases;May2014, Vol. 8 Issue 5, p1 

    Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease discovered in rural areas of Central China in 2009, caused by a novel bunyavirus, SFTS virus (SFTSV). The disease usually presents as fever, thrombocytopenia, and leukocytopenia, with case-fatality...

  • Chronic immune thrombocytopenic purpura-who needs medication? Bolton-Maggs, Paula H. B.; Kok, Victoria S. L. // Annals of Hematology;Jul2010, Vol. 89, p61 

    Chronic ITP (immune thrombocytopenic purpura; now defined as duration of more than 12 months) is not always associated with significant bleeding problems so that most children and adults can be managed expectantly with no medication unless surgery, accidents or other pathology mandate it. A...

  • Genetic studies in pediatric ITP: outlook, feasibility, and requirements. Bergmann, Anke K.; Grace, Rachael F.; Neufeld, Ellis J. // Annals of Hematology;Jul2010, Vol. 89, p95 

    The genomic revolution in medicine has not escaped attention of clinicians and scientists involved in medical management and research studies of immune thrombocytopenic purpura (ITP). In principle, ITP biology and care will benefit greatly from modern methods to understand the patterns of gene...

  • Treatment of chronic immune thrombocytopenic purpura in adults. Godeau, Bertrand; Michel, Marc // Annals of Hematology;Jul2010, Vol. 89, p55 

    Until recently, the management of refractory immune thrombocytopenic purpura (ITP) was a real challenge as shown by the large variety of treatments proposed in both American Society of Hematology and the British Committee for Standards in Haematology guidelines published 10 and 6 years ago,...

  • Platelet Disorders.  // New Harvard Guide to Women's Health;2004, p466 

    Presents a comprehensive women's health guide to blood platelet disorders. Epidemiology of immune thrombocytopenic purpura (ITP) and thrombotic thrombocytopenia purpura (TTP); Symptoms of ITP and TTP; Diagnosis and treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics